Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bethesda General Hospital
Researchers report details of new studies and findings in the area of diabetes therapy
October 9th, 2005
Diabetes therapy data are the focus of recent research from The Netherlands, Belgium and Italy. Study 1: Metformin does not decrease blood pressure in patients with type 2 diabetes intensively treated with insulin. "We investigated in a double-blind study whether metformin reduces blood pressure (BP) in patients with type 2 diabetes intensively treated with insulin. A total of 220 patients with type 2 diabetes were asked to undergo 24-hour ambulatory BP monitoring (24-hour ABPM). One hundred and eighty-two gave informed consent. Eighty-nine were randomized to metformin and 93 to placebo," investigators in the Netherlands report. ...
Source: Managed Care Law Weekly (2005-10-09)
|
